Literature DB >> 15569751

Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population.

Shuichi Suzuki1, Jeffrey L Saver, Phillip Scott, Reza Jahan, Gary Duckwiler, Sidney Starkman, Yafang Su, Chelsea S Kidwell.   

Abstract

BACKGROUND AND
PURPOSE: Intra-arterial therapies for ischemic stroke offer promise as a means to extend the time window for acute treatment. The purpose of this study was to identify the percentage of the US population with potential access to interventional neuroradiologic expertise within 6 hours of the onset of stroke symptoms.
METHODS: Hospital locations of interventional neuroradiologists were identified from the 2002 roster of the American Society of Interventional and Therapeutic Neuroradiology. Data for populations in surrounding regions were extracted from US Census 2001 data by zip code. Standard transport speeds for emergency medical services were used in our estimates of the population living within a 5-hour transport time, which was a 6-hour treatment window less a 1-hour door-to-needle time, resulting in a 200-mile radius. A 2-hour transport time, or 3-hour treatment window, reflected a 65-mile radius.
RESULTS: A total of 385 interventional neuroradiologists were identified, practicing in 45 states. With a 200-mile radius, 99% of the total US population had access to neurointerventional treatment within 6 hours of symptom onset. With a 65-mile radius, 82% of the population had access within 3 hours of symptom onset. Alaska and the Mid-Northwest region covering Idaho, Wyoming, North Dakota, and South Dakota had limited coverage.
CONCLUSION: Most of the US population has access to interventional neuroradiologic expertise for acute stroke therapy. These data suggest that interventional therapies that extend the time window for treating acute ischemic stroke could have a major effect on public health and merit further research development and investment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569751      PMCID: PMC8148724     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

Review 1.  Intra-arterial thrombolysis.

Authors:  J L Saver
Journal:  Neurology       Date:  2001       Impact factor: 9.910

2.  Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents.

Authors:  Scott L Silliman; Barbara Quinn; Vicki Huggett; José G Merino
Journal:  Stroke       Date:  2003-02-06       Impact factor: 7.914

3.  Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

Authors:  D Chiu; D Krieger; C Villar-Cordova; S E Kasner; L B Morgenstern; P L Bratina; F M Yatsu; J C Grotta
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

4.  Extending tissue plasminogen activator use to community and rural stroke patients.

Authors:  José G Merino; Brian Silver; Edward Wong; Blaine Foell; Bart Demaerschalk; Arturo Tamayo; Fali Poncha; Vladimir Hachinski
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

Review 5.  Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

Authors:  M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker
Journal:  JAMA       Date:  2000-06-21       Impact factor: 56.272

6.  Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI.

Authors:  D G Darby; P A Barber; R P Gerraty; P M Desmond; Q Yang; M Parsons; T Li; B M Tress; S M Davis
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

7.  Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI.

Authors:  P A Barber; D G Darby; P M Desmond; Q Yang; R P Gerraty; D Jolley; G A Donnan; B M Tress; S M Davis
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

8.  A comparison of the costs and performance of an emergency helicopter and land ambulances in a rural area.

Authors:  J P Nicholl; N R Beeby; J E Brazier
Journal:  Injury       Date:  1994-04       Impact factor: 2.586

9.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

10.  Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.

Authors: 
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

View more
  9 in total

1.  Our new journal.

Authors:  Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2008-01

2.  Geographic access to acute stroke care in the United States.

Authors:  Opeolu Adeoye; Karen C Albright; Brendan G Carr; Catherine Wolff; Micheal T Mullen; Todd Abruzzo; Andrew Ringer; Pooja Khatri; Charles Branas; Dawn Kleindorfer
Journal:  Stroke       Date:  2014-08-26       Impact factor: 7.914

3.  Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment.

Authors:  Wondwossen G Tekle; Saqib A Chaudhry; Zara Fatima; Maryam Ahmed; Shujaat Khalil; Ameer E Hassan; Gustavo J Rodriguez; Fareed K Suri; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2012-06

4.  Medical Specialties of Clinicians Providing Mechanical Thrombectomy to Patients With Acute Ischemic Stroke in the United States.

Authors:  Hooman Kamel; Caroline D Chung; Gbambele J Kone; Ajay Gupta; Nicholas A Morris; Matthew E Fink; Babak B Navi
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

5.  Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion.

Authors:  Jeremy D Fields; Pooja Khatri; Gary M Nesbit; Kenneth C Liu; Stanley L Barnwell; Helmi L Lutsep; Wayne M Clark; Maarten G Lansberg
Journal:  J Neurointerv Surg       Date:  2010-12-08       Impact factor: 5.836

Review 6.  Management of acute ischemic stroke.

Authors:  Alex Abou-Chebl
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

7.  Microcatheter contrast injections during intra-arterial thrombolysis may increase intracranial hemorrhage risk.

Authors:  Pooja Khatri; Joseph P Broderick; Jane C Khoury; Janice A Carrozzella; Thomas A Tomsick
Journal:  Stroke       Date:  2008-09-04       Impact factor: 7.914

8.  Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010.

Authors:  Jay Chol Choi; Renee Y Hsia; Anthony S Kim
Journal:  Stroke       Date:  2015-02-05       Impact factor: 7.914

9.  Stroke neuroprotection: targeting mitochondria.

Authors:  Lora Talley Watts; Reginald Lloyd; Richard Justin Garling; Timothy Duong
Journal:  Brain Sci       Date:  2013-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.